Latest Cost Savings News

Bapcor Limited has revised its first-half FY26 guidance to a statutory net loss, citing weaker trade segment performance and one-off costs, while maintaining a cautiously optimistic full-year outlook supported by cost savings and leadership changes.

Finder Energy has acquired the Petrojarl I FPSO from Amplus Energy for US$15 million, aiming to fast-track its KTJ oil development project with a targeted final investment decision by mid-2026 and first oil by the end of 2027. This move is supported by a two-tranche institutional placement raising A$25 million at a 21.3% discount.

Cuscal Limited has completed its acquisition of Indue Limited, targeting significant cost synergies and board refreshment to strengthen its payments business.

Greatland Resources has released a comprehensive feasibility study for its Havieron gold-copper project, outlining a long-life, low-cost operation fully funded through cash reserves and debt facilities. The study highlights robust economics and significant upside potential.

MyState Limited has reached a pivotal merger milestone by consolidating Auswide Bank under its single banking licence, aiming to unlock significant cost synergies while maintaining customer continuity.

Rapid Critical Metals has completed the acquisition of the Webbs Consol Silver Project, consolidating a high-grade silver belt in New South Wales and positioning itself for accelerated growth.

Gale Pacific’s FY25 results show resilience amid tariff challenges, with strategic manufacturing diversification and brand refresh underway to drive future growth.

Pioneer Credit has secured a further 15 basis point reduction on its $272.5 million senior finance facility, lowering its funding costs and reinforcing its commitment to sustainable business practices.

Temas Resources has completed a major drilling campaign at its La Blache project, targeting key critical minerals while progressing its innovative Regenerative Chloride Leach technology promising significant cost savings.

Ryman Healthcare reports a significant financial turnaround with its first positive free cash flow in over ten years, alongside upgraded sales and cost-saving targets for FY26 and completion of a major NZD 2 billion refinancing.

Ryman Healthcare has reported its first positive free cash flow in over a decade, driven by cost reductions and stronger sales momentum, while upgrading its sales guidance for FY26.

Proteomics International secures a key Medicare reimbursement rate for its PromarkerD test, a predictive diagnostic for diabetic kidney disease, marking a critical step in its US commercial rollout.